The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-arm phase II trial of palbociclib in combination with tamoxifen as first-line therapy for metastatic hormone receptor-positive breast cancer.
 
Oana Cristina Danciu
No Relationships to Disclose
 
Kent Hoskins
Research Funding - Abbvie (Inst); Merck Sharp & Dohme (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst)
 
Cristina I. Truica
Stock and Other Ownership Interests - GlaxoSmithKline
Honoraria - Daiichi Sankyo/Lilly; Puma Biotechnology; Seagen
Consulting or Advisory Role - Novartis
Speakers' Bureau - Daiichi Sankyo/Lilly; Puma Biotechnology; Seagen; Seagen
Research Funding - Novartis
 
Anne Hudson Blaes
No Relationships to Disclose
 
Deimante Tamkus
No Relationships to Disclose
 
Jatin Rana
No Relationships to Disclose
 
Pavankumar Tandra
No Relationships to Disclose
 
Lauren Green
Employment - University of Illinois- Chicago
Travel, Accommodations, Expenses - University of Illinois- Chicago
 
Menggang Yu
No Relationships to Disclose
 
Qianqian Zhao
No Relationships to Disclose
 
Deborah Toppmeyer
Employment - Merck (I); Novartis (I)
Stock and Other Ownership Interests - Merck (I); Novartis (I)
Honoraria - Novartis
Consulting or Advisory Role - Novartis
 
Ruth O'Regan
Honoraria - bioTheranostics; Genentech; Genomic Health; Immunomedics; Lilly; Macrogenics; Novartis; Pfizer; Puma Biotechnology; Seagen; Seagen
Consulting or Advisory Role - bioTheranostics; Genentech; Genomic Health; ImmunogenX; Lilly; Macrogenics; Novartis; Puma Biotechnology; Seagen
Research Funding - Eisai (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genomic Health; Immunomedics; Lilly; Macrogenics; Puma Biotechnology
 
Kari Braun Wisinski
Consulting or Advisory Role - AstraZeneca; Genomic Health; Pfizer; Sanofi
Research Funding - AstraZeneca (Inst); Context Therapeutics (Inst); Genentech (Inst); Novartis (Inst); Oncoceutics (Inst); Pfizer; Pfizer; Sanofi (Inst)